Evidence map›Paper›PMID 30410476›Full record

ArticleFrontiers in microbiology2018

Antimicrobial and Antibiofilm Activity of Synergistic Combinations of a Commercially Available Small Compound Library With Colistin Against

Nelson S Torres, Daniel Montelongo-Jauregui, Johnathan J Abercrombie, Anand Srinivasan, Jose L Lopez-Ribot, Anand K Ramasubramanian, Kai P Leung

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Busulfan inhibitsFrontiers in cellular and infection microbiology · 2025
    Article
  9. Article
  10. Article
  11. Edeine BmBio · 2024
    Article
  12. Article
  13. The use of combination therapy for the improvement of colistin activity against bacterial biofilm.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. L007-0069 kills Staphylococcus aureus in high resistant phenotypes.Cellular and molecular life sciences : CMLS · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nelson S TorresDental and Craniofacial Trauma Research and Tissue Regeneration Directorate, Institute of Surgical Research, San Antonio, TX, United States.
Daniel Montelongo-JaureguiDepartment of Biology, South Texas Center for Emerging Infectious Diseases, The University of Texas at San Antonio, San Antonio, TX, United States.
Johnathan J AbercrombieDental and Craniofacial Trauma Research and Tissue Regeneration Directorate, Institute of Surgical Research, San Antonio, TX, United States.
Anand SrinivasanDepartment of Biomedical Engineering, The University of Texas at San Antonio, San Antonio, TX, United States.
Jose L Lopez-RibotDepartment of Biology, South Texas Center for Emerging Infectious Diseases, The University of Texas at San Antonio, San Antonio, TX, United States.
Anand K RamasubramanianDepartment of Chemical and Materials Engineering, San José State University, San José, CA, United States.
Kai P LeungDental and Craniofacial Trauma Research and Tissue Regeneration Directorate, Institute of Surgical Research, San Antonio, TX, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biofilm-associated

Indexed as

antibiofilmcolistindrug combinationsdrug repositioningprestwick chemical librarypseudomonas aeruginosasynergyzero interaction potency

Identifiers

PMID30410476
PMCPMC6209680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.